Related Experiment Video
Updated: Nov 17, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances
Patricia Mangan1, Edward Stadtmauer1
1Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract:
At JADPRO Live 2019, Patricia Mangan, RN, MSN, CRNP, and Edward Stadtmauer, MD, discussed the emerging world of chimeric antigen receptor (CAR) T-cell therapy, including the CAR T-cell process, approved indications and studies in hematologic malignancies, strategies for monitoring and managing emerging toxicities, and future directions in the use of this novel therapy.
Related Concept Videos
iPS Cell Differentiation
Tumor Immunotherapy
Forced Transdifferentiation
Artificial...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

